They not only reduce inflammatory markers by modulating the NF-κB and Nrf2 pathways but also restore gut microbial balance, effectively ameliorating 2,4 dinitrobenzensulfuric acid (DNBS)-induced colitis (Tinnirello et al., 2024). The gene discussed is NFKB1; the disease is colitis.